Deviation – Page 100

Labeling deviation in veterinary product manufacturing: regulatory communication strategy

Addressing Labeling Deviations in Veterinary Product Manufacturing: An Investigation Guide Labeling deviations in veterinary product manufacturing present significant challenges that can jeopardize product integrity, regulatory compliance, and ultimately, market access.…

Tablet lamination defect during campaign changeover – process vs formulation assessment

Addressing Tablet Lamination Defects During Changeover: A Comprehensive Investigation Guide In the high-stakes environment of pharmaceutical manufacturing, defects such as tablet lamination can pose significant challenges, especially during campaign changeovers.…

Inventory reconciliation mismatch during warehousing: CAPA and security controls

Examining Inventory Discrepancies in Warehousing: A Detailed Investigation Framework Inventory reconciliation mismatches during warehousing can pose significant challenges for pharmaceutical manufacturers, leading to potential compliance issues, regulatory scrutiny, and operational…

Stability failure during inspection prep: GMP investigation and CAPA

“`html Investigating Stability Failures During Inspection Preparation: A Practical Approach Stability failures during inspection preparation can lead to significant implications for pharmaceutical manufacturers, particularly in the veterinary sector. With the…

Sticking and picking after tooling change – CAPA failure identified

Understanding Sticking and Picking Issues Following Tooling Changes in Pharmaceutical Manufacturing In the world of pharmaceutical manufacturing, deviations from standard production processes can lead to significant quality concerns and regulatory…

Diversion risk signal during warehousing: CAPA and security controls

Diversion Risk Signals During Warehousing: Effective Investigation and CAPA Strategies In the pharmaceutical industry, maintaining strict control over controlled substances during warehousing is paramount. A diversion risk signal can indicate…

Stability failure during regulatory submission: risk assessment for animal and food safety

“`html Investigating Stability Failures During Regulatory Submissions for Veterinary Medicines Stability failures during regulatory submissions pose significant risks to pharmaceutical manufacturers, particularly in the realm of veterinary medicines. Such failures…

Disintegration time failure during high-speed runs – root cause analysis breakdown

Understanding and Investigating Disintegration Time Failures during High-Speed Runs In pharmaceutical manufacturing, ensuring that tablets meet stringent disintegration time specifications is crucial for product efficacy and consumer safety. A failure…

Chain of custody breach during distribution: inspection-ready documentation

Understanding Chain of Custody Breaches During Distribution: Essential Documentation for Inspection Readiness In the pharmaceutical manufacturing sector, maintaining a secure and documented chain of custody during distribution is imperative for…

Assay OOS during stability studies: GMP investigation and CAPA

Investigation of Assay OOS Results During Stability Studies in Veterinary Medicines Out-of-Specification (OOS) results during stability studies can pose significant challenges in pharmaceutical manufacturing, particularly within the veterinary sector. These…

Weight variation failure during campaign changeover – FDA inspection observation risk

Addressing Weight Variation Failures During Campaign Changeover: An Investigation Framework Weight variation failures during campaign changeover pose a significant risk in pharmaceutical manufacturing. Such incidents can result in non-compliance with…

Chain of custody breach during distribution: regulatory enforcement risk mitigation

Risk Mitigation for Chain of Custody Breach During Distribution in Pharma In the pharmaceutical industry, maintaining the integrity of controlled substances throughout the distribution chain is critical. Breach of chain…